Nuclear Medicine Washington, DC - 20060

Nuclear Medicine is categorized under Internal Medicine Doctors in Washington, DC and active since 1984.

Nuclear Medicine was established in 1984, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 621111 by the NAICS.

If you are seeking more information, feel free to contact Willie Mcdaniel at the company’s single location by writing to 2041 Georgia Avenue Nw, Washington, District of Columbia DC 20060 or by phoning (202) 865-1996. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Nuclear Medicine
Contact Person: Willie Mcdaniel
Address: 2041 Georgia Avenue Nw, Washington, District of Columbia 20060
Phone Number: (202) 865-1996
Website Address: nuclearmedicine.com
Annual Revenue (USD): $100.000 to $499.999
Founded: 1984
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Doctors
SIC Code: 8011
NAICS Code: 621111
Share This Business:

Nuclear Medicine was started in 1984 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Willie Mcdaniel for inquiries that concern Nuclear Medicine by calling the company number (202) 865-1996, as your correspondence is most welcome. Additionally, the physical location of the single location of Nuclear Medicine can be found at the coordinates 38.916885,-77.021733 as well as the street address 2041 Georgia Avenue Nw in Washington, District of Columbia 20060.

For its online presence, you may visit Nuclear Medicine’s website at nuclearmedicine.com and engage with its social media outlets through on Twitter and on Facebook.